rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

524816 NATCO Group (B)

Natco Pharma Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
715.65   7.65   1.08%
Volume 11,383
Prev close 708.00
Day's H/L (Rs.) 725.00 - 709.25
52wk H/L (Rs.) 877.00 - 390.00
Mkt Cap (Rs. Cr) 2,404.58
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

NATCOPHARM

Natco Pharma Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
714.65   7.95   1.12%
Volume 43,963
Prev close 706.70
Day's H/L (Rs.) 725.45 - 709.05
52wk H/L (Rs.) 878.00 - 422.05
Turnover (Rs. Lacs) 315.55
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Natco Pharma Ltd.  (See all 90 market voices)   

140 Characters
  Cancel
Shibu Dc - 04 Apr 2014 no chance
#Natco-Pharma-Ltd
Reply   |   Share
Shibu Dc - 04 Apr 2014 if it cross Rs 768 today i never trade again
#Natco-Pharma-Ltd
Reply   |   Share
Deepesh Gupta - 2 weeks ago  Ok so you are out of trading now because it will go up !
Reply   |  Share
Praneeth Kumar - 2 weeks ago  shibu darr ge aage jeet hai ;)...well patience is key for trading..
Reply   |  Share

Realtime news for Natco Pharma Ltd. (See all 506 news)

18 April 2014, 18:40
Natco Pharma urges Indian patent office to deny Gilead's hepatitis C drug patent in India: Report - 11 Apr 2014
Copycats trip as patent holders hawk variants, tweak dosage - 2 day(s) ago
Teva's application for patent extension on Copaxone rejected - 08 Apr 2014
Natco Pharma upbeat on Copaxone launch - 04 Apr 2014
Teva entreats SCOTUS to block Copaxone generics till patent case wraps - 08 Apr 2014

BSE Announcements from Natco Pharma Ltd. (See all)

Shareholding Pattern for March 31, 2014 - 6 day(s) ago
United States PTO Rejects Teva's '808 Patent Reissue Application on Copaxone(R) for the Second Time - 04 Apr 2014

Company details for Natco Pharma Ltd.

Report Card

PE Ratios
28.73
EPS (Rs.)
24.91
Sales (Rs. Cr)
174.23
Face Value (Rs.)
10
Net Profit
Margin (%)
 
13.71
Last Bonus
Last Dividend(%)
50
Return on
Average Equity
 
14.53

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Natco Pharma Ltd. performance snapshot

If you had invested Rs.  in Natco Pharma Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Natco Pharma Ltd. with other stocks

Apollo Hospitals Enterprise Ltd.
886.55
GlaxoSmithKline Pharmaceuticals Ltd.
2,508.10
Show more companies
Apollo Hospitals Enterprise Ltd.
886.55
GlaxoSmithKline Pharmaceuticals Ltd.
2,508.10
Glenmark Pharmaceuticals Ltd.
583.10
Strides Arcolab Ltd.
453.55
Aurobindo Pharma Ltd.
548.00
Lupin Ltd.
953.05
Divi's Laboratories Ltd.
1,323.45
Dr. Reddy's Laboratories Ltd.
2,539.35
Ranbaxy Laboratories Ltd.
466.15
Biocon Ltd.
455.75
Show less companies
Close
Add Natco Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Natco Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close